Schnell M J, Johnson J E, Buonocore L, Rose J K
Department of Pathology, Yale University School of Medicine, New Haven, Connecticut 06510, USA.
Cell. 1997 Sep 5;90(5):849-57. doi: 10.1016/s0092-8674(00)80350-5.
We describe a recombinant vesicular stomatitis virus lacking its glycoprotein gene and expressing instead the HIV-1 receptor CD4 and a coreceptor, CXCR4. This virus was unable to infect normal cells but did infect, propagate on, and kill cells that were first infected with HIV-1 and therefore had the HIV membrane fusion protein on their surface. Killing of HIV-1-infected cells controlled HIV infection in a T cell line and reduced titers of infectious HIV-1 in the culture by as much as 10(4)-fold. Such a targeted virus could have therapeutic value in reducing HIV viral load. Our results also demonstrate a general strategy of targeting one virus to the envelope protein of another virus to control infection.
我们描述了一种重组水疱性口炎病毒,该病毒缺失其糖蛋白基因,转而表达HIV-1受体CD4和一种共受体CXCR4。这种病毒无法感染正常细胞,但确实能感染、在首次感染HIV-1因而表面有HIV膜融合蛋白的细胞上增殖并杀死这些细胞。杀死HIV-1感染细胞可在T细胞系中控制HIV感染,并使培养物中传染性HIV-1的滴度降低多达10⁴倍。这种靶向病毒在降低HIV病毒载量方面可能具有治疗价值。我们的结果还证明了一种将一种病毒靶向另一种病毒的包膜蛋白以控制感染的通用策略。